Evidence map›Paper›PMID 24500422›Full record

ArticleSubstance abuse and rehabilitation2012

Prevention interventions for human immunodeficiency virus in drug-using women with a history of partner violence.

Jamila K Stockman, Natasha Ludwig-Barron, Monica A Hoffman, Monica D Ulibarri, Typhanye V Penniman Dyer

Open access · goldAbstract read
In one paragraph

Article in Substance abuse and rehabilitation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jamila K StockmanDivision of Global Public Health, Department of Medicine, San Diego, La Jolla, CA.
Natasha Ludwig-BarronDivision of Global Public Health, Department of Medicine, San Diego, La Jolla, CA.
Monica A HoffmanDepartment of Communication and Science Studies, San Diego, La Jolla, CA.
Monica D UlibarriDepartment of Psychiatry, University of California, San Diego, La Jolla, CA.
Typhanye V Penniman DyerDepartment of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD, USA.
Center for Global Health · USUniversity of California, San Diego · US

Funding

Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
UCLA Implementation Science and Substance Use Research and Education (ISSURE) ProgramR25DA035692 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TIMOTHY W FONG, GAIL E. WYATT · 2013 to 2026
$3.9M
Impact of Violence and Power on a HIV Behavioral Intervention for Female MA UsersK01DA031593 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STOCKMAN, JAMILA KINSHASA · 2011 to 2015
$897k
Dyad-level Predictors of HIV Risk Among High-risk Couples in Tijuana, MexicoK01DA026307 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ULIBARRI, MONICA DEANNE · 2010 to 2014
$787k
Center for HIV/AIDS Minority Pipeline in Substance Abuse Research (CHAMPS)R25DA025571 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2008 to 2010
$784k
HIV/AIDS: Translational Approaches and Health DisparitiesR25MH080664 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WYATT, GAIL E. · 2009 to 2011
$580k
NIDA NIH HHS K01 DA026307NIDA NIH HHS K01 DA031593NIDA NIH HHS R25 DA025571NIDA NIH HHS R25 DA035692NIDA NIH HHS T32 DA023356NIMHD NIH HHS L60 MD003701NIMH NIH HHS R25 MH080664
6 · The paper itself

Abstract

The intersecting epidemics of human immunodeficiency virus (HIV) and partner violence disproportionately affect women who use drugs. Despite accumulating evidence throughout the world linking these epidemics, HIV prevention efforts focused on these synergistic issues as well as underlying determinants that contribute to the HIV risk environment (eg, housing instability, incarceration, policing practices, survival sex) are lacking. This article highlights selected behavior change theories and biomedical approaches that have been used or could be applied in HIV prevention interventions for drug-using women with histories of partner violence and in existing HIV prevention interventions for drug-using women that have been gender-focused while integrating histories of partner violence and/or relationship power dynamics. To date, there is a paucity of HIV prevention interventions designed for drug-using women (both in and outside of drug treatment programs) with histories of partner violence. Of the few that exist, they have been theory-driven, culture-specific, and address certain aspects of gender-based inequalities (eg, gender-specific norms, relationship power and control, partner violence through assessment of personal risk and safety planning). However, no single intervention has addressed all of these issues. Moreover, HIV prevention interventions for drug-using women with histories of partner violence are not widespread and do not address multiple components of the risk environment. Efficacious interventions should target individuals, men, couples, and social networks. There is also a critical need for the development of culturally tailored combination HIV prevention interventions that not only incorporate evidence-based behavioral and biomedical approaches (eg, microbicides, pre-exposure prophylaxis, female-initiated barrier methods) but also take into account the risk environment at the physical, social, economic and political levels. Ultimately, this approach will have a significant impact on reducing HIV infections among drug-using women with histories of partner violence.

Indexed as

acquired immune deficiency syndromedrugsgender-based inequalitieshuman immunodeficiency virusinterventionspartner violencewomen

Identifiers

PMID24500422
PMCPMC3280816
OpenAlexW2153182371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.